跳至主要内容
临床试验/CTRI/2022/07/043896
CTRI/2022/07/043896已完成2 期

A comparative clinical evaluation of Mahatriphala ghrita in the management of the chemo toxicity in head & neck cancer -An open labeled randomized clinical trial

Government Akhandanad Ayurveda College0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Patients have diagnosed head & neck carcinoma.
  • 2) Patients who are undergo for 2nd, 3rd and 4th line of treatment of cancer.
  • 3) Patients who give consent for Ayurvedic treatment.

排除标准

  • 1) Patients having age < 18 years and > 60 years.
  • 2) patients having brain cancer(vital organ damage)
  • 3) Patients having any other pre-existing chronic illness like- AIDS, DM, CKD, IHD.
  • 4) Patients who are under post-operative care.
  • 5) Patients who are NBM.
  • 6) Patients who have cachexia(Bala Mamsa-Praman hina)
  • 7) Patients who are suffering from constant diarrhoea, vomiting.
  • 8) Patients who have history of long-term toxicity of radio/chemo therapy.
  • 9) Associated with any other serious systemic disease or complications, which leads to fatal conditions will be excluded.

研究者

发起方
Government Akhandanad Ayurveda College

相似试验